Home » Topics » BioWorld Science

BioWorld Science
RSS

Intranasal influenza-based boost vaccination for preventing SARS-CoV-2 infection

Jan. 17, 2022

AstraZeneca and Scorpion collaborate on therapeutics against transcription factors for cancer

Jan. 17, 2022

Targeting IP3R-mediated Ca2+ homeostasis in adipocytes as strategy against metabolic disease

Jan. 17, 2022

New 3,5-diaryl-substituted pyrazoles inhibit prostate cancer cell growth

Jan. 17, 2022

Viral replication inhibitors patented by Gilead

Jan. 17, 2022

New glucocorticoid receptor antagonists discovered at Corcept Therapeutics

Jan. 17, 2022

Celgene presents new cereblon-binding PROTACs

Jan. 17, 2022

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Jan. 17, 2022

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

Jan. 17, 2022

Machine learning approach speeds resistance identification

Jan. 17, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...